Financials • Investment Managers
$40.57 ▲ +1.51
(+3.87%)
MKT CAP: $14.46B • VOL: 3.05M
52W L $35 52W H $67
CG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.78B | $5.43B | $2.96B |
| YoY Revenue Growth % | -11.9% | +83.1% | — |
| Gross Profit | $2.10B | $2.39B | $1.30B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $954.3M | $1.20B | -$717.9M |
| Operating Margin % | 20.0% | 22.2% | -24.2% |
| Net Income (GAAP) | $808.7M | $1.02B | -$608.4M |
| EBITDA (Normalized) | $1.03B | $1.27B | -$611.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.28B | -$759.5M | $204.9M |
| Capital Expenditures (CapEx) | $99.4M | $77.7M | $133.4M |
| Free Cash Flow (FCF) | -$3.37B | -$837.2M | $71.5M |
| FCF Margin % | -70.6% | -15.4% | 2.4% |
| Return on Invested Capital (ROIC %) | 5.0% | 7.5% | -11.8% |
| Cash & Short-Term Equivalents | $1.97B | $1.27B | $874.6M |
| Total Debt (Short + Long Term) | $9.93B | $7.54B | $1.86B |
| Total Stockholders' Equity | $7.06B | $6.35B | $3.82B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CG.